Wu Xing, Cui Lisha, Bai Yu, Bian Lianlian, Liang Zhenglun
Division of Hepatitis Virus & Enterovirus Vaccines, Institute for Biological Products, National Institutes for Food and Drug Control, Beijing, China.
WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.
Adv Exp Med Biol. 2023;1407:209-228. doi: 10.1007/978-981-99-0113-5_11.
Using a non-pathogenic pseudotyped virus as a surrogate for a wide-type virus in scientific research complies with the recent requirements for biosafety. Enterovirus (EV) contains many species of viruses, which are a type of nonenveloped virus. The preparation of its corresponding pseudotyped virus often needs customized construction compared to some enveloped viruses. This article describes the procedures and challenges in the construction of pseudotyped virus for enterovirus (pseudotyped enterovirus, EVpv) and also introduces the application of EVpv in basic virological research, serological monitoring, and the detection of neutralizing antibody (NtAb).
在科学研究中使用非致病性假型病毒作为野生型病毒的替代物符合近期生物安全要求。肠道病毒(EV)包含多种病毒,属于非包膜病毒类型。与一些包膜病毒相比,其相应假型病毒的制备通常需要定制构建。本文描述了肠道病毒假型病毒(pseudotyped enterovirus,EVpv)构建的程序和挑战,并介绍了EVpv在基础病毒学研究、血清学监测和中和抗体(NtAb)检测中的应用。